RECURRENT NON SMALL CELL LUNG CANCER
Clinical trials for RECURRENT NON SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT NON SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for RECURRENT NON SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced lung cancer? trial tests adding a third drug to standard treatment
Disease control OngoingThis study is testing if adding a new drug called relatlimab to a standard treatment (nivolumab plus chemotherapy) works better for people with advanced or recurrent non-small cell lung cancer. It will involve about 468 adults who have not yet received treatment for their advance…
Matched conditions: RECURRENT NON SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Precision radiation blitz tested to fight tough lung cancers
Disease control OngoingThis study is testing a new way to deliver radiation therapy along with standard chemotherapy for people with stage II or III non-small cell lung cancer that cannot be removed by surgery. The goal is to see if a more targeted, higher-dose radiation schedule can kill more cancer c…
Matched conditions: RECURRENT NON SMALL CELL LUNG CANCER
Phase: NA • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC